Cytotherapy

Cytotherapy is the Official Journal of the International Society for Cellular Therapy (ISCT).

Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians, and regulatory experts involved in cell processing and therapy.

The journal's scope includes research in:

• Stem cell processing and transplantation
• Cell-based therapies of malignant and non-malignant blood diseases
• Cancer
• Stem cell plasticity
• Autoimmune diseases
• Immunotherapy
• Congenital disorders
• Novel molecular therapies
• Gene therapy
• Microvesicle biology and therapeutic application

Editor in Chief: John Barrett, MD
Organizational Affiliations: International Society for Cellular Therapy (ISCT)
2023
Cytotherapy
Global Print Circulation
315
Avg. Global Monthly Visits
10,738
Avg. Global Monthly Unique Visitors
8,441
Avg. Global Monthly Page Views
18,681
Avg. Global eTOC Distribution
5,701
Circulation updated on August 18th, 2022, based on 12-month monthly average July 2021-June 2022. eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023

Contacts

Display Advertising

Recruitment Advertising

Looking for more information?

If you would like to be contacted by one of our advertising experts, please complete our Request Contact form and we will get right back to you.